messag mondelez result ahead expect despit lower gross
margin transient issu brazil persist least manag
increas underli guidanc year sale ep continu
see flexibl compani beat reduc ep estim
 due
stronger gross margin pressur lower jv earn year price
mondelez report strong organ sale growth beat estim
thank primarili strong volum growth europ gross margin fell bp
short estim perhap one-third miss come suppli chain issu
powder beverag categori weak brazil despit oper incom miss
estim roughli ep ahead estim due
benefit lower interest expens benefit tax benefit
full year ep manag rais organ sale growth guidanc
currency-neutr ep growth said fx
would neg impact ep net impli midpoint
ep guidanc remain unchang howev continu think degre
conservat guidanc organ sale growth ep estim
rang respect remain posit mondelez due
organ shift prioriti growth brand reinvest away year
hyper-focu margin expans see clear proof progress compani find
foot us build scale intern
europ lead growth europ strong quarter organ growth driven
entir volum exceed expect drove almost half
compani global organ growth manag said region benefit
prolong well easier comparison due heat wave year-ago
quarter uk particularli strong double-digit revenu growth driven chocol
categori growth share gain solid execut addit segment oper
margin increas bp despit higher brand invest increas
sale growth estim europ assum sequenti
deceler sustain growth level
chang model expect manag origin organ sale growth
guidanc prove overli conserv manag expect
ytd given reduc organ sale growth estim
maintain estim full year lower ep estim year
remain manag impli ep guidanc rang
base dont see meaning upsid continu think
manag inclin over-invest over-earn revis ep estim
incorpor lower gross margin better account headwind brazil subtract
benefit lower interest expens add reduc jv earn
subtract lower tax rate add go forward
continu expect roughli ep growth lower base
page analyst certif import disclosur
valuat risk
price target assum multipl discount earn pe
repres premium food coverag trade around pe given higher
expect organ sale growth compound-annual-growth-rate ep growth estim versu food peer
intern sale exposur especi emerg market favor categori
exposur option associ coffe invest
risk valuat
risk downsid includ
global recess current uncertainti market chanc global
recess like sale slowdown start observ throughout
world compani high intern exposur close could
neg impact compani sale
us gum declin continu although compani announc specif initi
help revers gum declin uncertainti abl could
limit organ sale growth entir compani gum profit
categori compani margin expans could limit result
privat label privat label alreadi neg impact mani compani
categori continu grow may continu pace faster
expect allow privat label rapidli take share mani compani
categori limit sale expans
page analyst certif import disclosur
page analyst certif import disclosur
incom million except per emar y-o-i growth na cost good gross gross sell gener expens total oper sg oper oper y-o-i growth na ebitda y-o-i growth na net interest incom incom tax non-control incom adj dilut y-o-i growth dilut share sale breakdownvolum acquisit extra week net sale organ food produc
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic mondelez
inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori inc
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
